Heddington, United Kingdom

Rodney Dunbar


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Rodney Dunbar

Introduction

Rodney Dunbar is a notable inventor based in Heddington, GB. He has made significant contributions to the field of immunology through his innovative work on peptide derivatives. His research focuses on the development of peptides that can enhance immune responses, particularly in the context of cancer treatment.

Latest Patents

Rodney Dunbar holds 1 patent for his invention titled "NY-ESO-1 peptide derivatives, and uses thereof." This invention relates to variant peptides that bind to HLA molecules, leading to the lysis of cells via cytolytic T cell lines. The variants are based on NY-ESO-1 peptides, which can be incorporated into immune tetramers, making them useful as T cell sorters.

Career Highlights

Dunbar's career is marked by his association with Oxford University Innovation Limited, where he has been able to translate his research into practical applications. His work has the potential to significantly impact cancer immunotherapy, providing new avenues for treatment.

Collaborations

Throughout his career, Rodney Dunbar has collaborated with esteemed colleagues such as Vincenzo Cerundolo and Ji-li Chen. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Rodney Dunbar's innovative work in peptide derivatives showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…